Search

Your search keyword '"Tosetto, A."' showing total 86 results

Search Constraints

Start Over You searched for: Author "Tosetto, A." Remove constraint Author: "Tosetto, A." Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
86 results on '"Tosetto, A."'

Search Results

2. More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

3. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

4. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

6. Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

7. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

8. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

9. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study

11. Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature

12. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

13. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

14. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

15. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study

16. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

17. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

21. Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia

22. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

25. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

31. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

35. Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

49. von Willebrand disease: proposing definitions for future research

50. Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life Study of 558 Patients

Catalog

Books, media, physical & digital resources